GlucaGen

Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)

Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)

Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients

Very Low Carbohydrate Diets and Glucagon Response in T1DM

Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome

The T1D Exchange Registry

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes

Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus

Genetics of the Acute Response to Oral Semaglutide

Splanchnic Venous Capacitance in Postural Tachycardia Syndrome

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction

Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes

Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes

Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Effects of GH and Lirglutide on AgRP

Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity

Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity

The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients

GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH

Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment

Impact GLP-1 Agonists Following Bariatric

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.

GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery

Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery

Fibrosis Lessens After Metabolic Surgery

Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide

Insulin and Insulin Pulses During Fasting

Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 Diabetes

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy

Effect of C-peptide on Hypoglycemic Counterregulation

Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition

Tirzepatide Weight Loss for MRD+ Early Breast Cancer

Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer

The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease

GLP-1R Agonist Treatment for Opioid Use Disorder

Glucagon-Like Peptide-1 Receptor Agonist in ADPKD

Graded Insulin Suppression Test P&F

The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease

GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes

Development of a Non-invasive Method for Quantifying Cerebral Glucose Metabolism for Studying the Effect of Glucagon in Humans

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor (GLP-1 RA) Agonist Prior to Anesthesia

Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide

Gastric POCUS for Airway Management in Patients Using Glucagon-like Peptide-1 Receptor Agonist (Multicentric)

iGlarLixi CGM Study in Chinese T2D Individuals After OADs

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

2024 Tirzepatide-Bariatric Surgery

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

Study of Tirzepatide for Recovery and Alcohol Use Management

MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

Liraglutide Treatment in Obese Infertile PCOS Women

A Study of a Weight Loss Intervention in People With Endometrial Cancer

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes

Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation

Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults

Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes

Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes

The Evira Study: Additional Support During Obesity Treatment

Effect of Fasting Recommendations Among Patients Using GLP-1 Receptor Agonists

Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function.

A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes

Tirzepatide in PWS, HO and GNSO

Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy

A Study of BGM0504 in Participants With Obesity

Effect of Tirzepatide on Markers of MASLD in Patients With Obesity

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

Tirzepatide for Alcohol Use Disorder

Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema

Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis

POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS

Food and Fitness With Medicine (FFWM)

Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)

Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity

Tirzepatide in MetALD

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

Rebalancing the Fat Content of the Heart and Muscles

Tirzepatide in Obesity-Driven Endometrial Cancer

Healthy Living BEYOND Weight Study

Effects of GLP-1 Formula on GLP-1 and Glucose Regulation

A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)

Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity

Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024

Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors

Tirzepatide Use in People With Obesity and Type 1 Diabetes

A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)

A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia

Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

GLP-1R Actions on Muscle and the Skeleton

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)

Tirzepatide in Idiopathic Intracranial Hypertension Trial

Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

Phase I Study of XTL6001 Injection in Healthy and Obese Subjects

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes

The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric Surgery

The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity

Tirzepatide to Slow Biological Aging

Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)

Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity

A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control

Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity

Glucagon Resistance in Patients With MASLD and T2DM

A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis

A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity

Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD

Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes

A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese

A Clinical Trial Evaluating TQF3250 Capsules in Healthy Adult Subjects

Bariatric Surgery Combined With GLP-1 Receptor Agonists Study

A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults

Tirzepatide and Muscle Outcomes in Obesity

Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation

Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion

TED_ORG: Study on Short Bowel Syndrome

Tirzepatide (Spartina) in Obese Kidney Transplant Recipients

The Postprandial Hypo-Avoid Study

Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis

Transformative Research in Diabetic Nephropathy 2.0

A Study to Evaluate ALN-2232 in Participants With Obesity

Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight

Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes

Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Incretin Therapies in Obesity-related HFpEF

Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes

Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)

Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion

Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.

Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs

Multi-Site Trial of Tirzepatide for Smoking Cessation

A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight

GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity

Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases

A Clinical Study of FT1 in Patients With Short Bowel Syndrome

A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants

Bariatric Surgery Combined With GLP-1RA: A Multicenter Study.

Tirzepatide for Treatment of CCCA

A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)

Gestational Response, Outcomes, and Weight After GLP-1 Use

A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity

Cardiovascular-kidney-metabolic (CKM)-Guided Therapy for Patients After Acute Coronary Syndrome

Weight and Metabolic Management Study

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

Charactertizing Growth Hormone Deficiency in Traumatic Brain Injury

Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor Agonists

A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity

Post-Prandial Carbohydrate Metabolism in Individuals With and Without Post-Bariatric Surgery Hypoglycemia (PBH)

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight

Diagnosis and Treatment of Pheochromocytoma

Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion

NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes

Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials

Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes

Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography

Plasma Determination of Glucagon-like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure

The Role of Amylin and Glucagon in T1DM

Acute Metabolic Effects of LAF 237 in Type 2 Diabetics

The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men

The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism

Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure

The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans

GLP-1 Infusion and Long-Time Fasting

To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c

A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes

Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes

Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes

The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia

The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes

Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers

A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Glucagon Like Peptides Receptors Expression in the Stomach of Diabetes Type 2

Glucose Metabolism in the Immediate and Short Term Follow up After Bariatric Surgery

Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM

Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes

Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes

Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.

New Frontiers on Bariatric Surgical Procedures: Classical Bypass for Type-2 Diabetic Patients With Obesity Grade I

Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal Study

Surgical Treatment of Non-obese Type 2 Diabetic Patients With Duodenal Exclusion

Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism

GLP1R Polymorphisms and Response to GLP1

Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus

Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates

Near Normalisation of BG Improves the Potentiating Effect of GLP-1

Beta-Cell Function After Near-Normalisation of Blood Glucose

Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes

The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus

Incretin Physiology and Beta-cell Function Before and After Weight-loss

PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus

The Role of Small Intestinal Endocrine Cells in Type 2 Diabetic Hyperglucagonemia

Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects

Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus

Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome

Effects of Glutamine on GLP-1 and Insulin Secretion in Man

The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body Composition

Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon

A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide

The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus

Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes

Incretin Physiology Associated With Steroid Hormone Treatment

GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia

The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes

Glycemic Rises After Waking Up In Response To An Alarm Clock In Type 1-Diabetic Patients Analysed With Continuous Glucose Monitoring (GlucoDay®)

Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men

Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers

How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.

To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo

Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass

Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance

Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone

The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients

Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure

Randomized Trial of ERCP Then Laparoscopic Cholecystectomy vs. Laparoscopic Cholecystectomy Plus Laparoscopic Common Bile Duct Exploration in Patients With Likely Choledocholithiasis

Closed-loop Glucose Control for Automated Management of Type 1 Diabetes

To Evaluate the Response to Glucagon During Hypoglycemia

A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects

n-3 Fatty Acid Infusion and Type 2 Diabetes

Comparison Between Patients With or Without Diabetes Recovery After Bariatric Surgery

Effect of Exendin (9-39) on Glucose Requirements to Maintain Euglycemia

Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old

The Aging Endocrine Pancreas: Characterization of the Entero-insular Axis Physiology in the Elderly

Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism

Effect of Sitagliptin on Graft Function Following Islet Transplantation

Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic Syndrome

The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes

Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients

Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)

Characterization of Beta Cell Failure

Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir

Amylin and Glucagon-Like Peptide-1 (GLP-1): Influence on Gastric Emptying, Appetite and Food Intake in Humans

"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"

Intravenous Exenatide (Byetta) During Surgery

GLP 1 for Intraoperative Glycemic Control

A Pilot Study to Evaluate the Glucagon-Like Peptide 1 Response to the Challenge of Mixed Meals in Chinese Subjects

Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity

Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus

Glucagon Modulation of Ghrelin Secretion

Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients

Effects of Intravenous Infusions of Gut Hormones on Appetite and Metabolism.

Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes

Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)

The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes

Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) Surgery

Predictive Parameters for Efficacy of Sitagliptin and Metformin Combination

A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers

GLP-1 - Regulatory Mechanism of Postprandial Glycemia

Safety and Tolerability of NN9068 in Healthy Male Volunteers

A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 Diabetics

Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes

Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes

Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes

Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients

Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus-2

GIP and GLP-1 on Gastric Emptying, Appetite and Insulin-glucose

Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity

Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY

Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure

A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 Diabetes

Relationship Between Changes in Gut Hormones After Gastric Bypass and Gastric Banding and Improvements in Diabetes

Acute Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon

Integration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial Pancreas

Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia

Insulinotropic Effect of GIP and GLP-1 Before and After Reduced Glucose Tolerance

Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes

Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretion

Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects

Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) Effects

Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results

Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)

Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation

Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus

A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India

Dose-response Study of Exendin-9,39 on Glucose Metabolism

Vildagliptin and the Glucagon Response to Hypoglycemia in Insulin-Treated Patients With Type 2 Diabetes

Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes

Oxyntomodulin, Mechanisms of Action in Relation to Appetite, Food Intake, Gastric Emptying and Energy Expenditure.

Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake

Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)

Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis

Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial)

Real-time Adaptation to Changes in Insulin Sensitivity

LIraglutide and Beta-cell RepAir (LIBRA) Study

Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes

Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes

Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery

Study of Postprandial Incretin Response in Women With Gestational Diabetes

The Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic Axis

Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes

Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)

Closed-loop Control of Glucose Levels in the Context of Exercise in Adults With Type-1 Diabetes

GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage

Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus

Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose

Role of the Gut Sweet Taste Receptor in the Secretion of Glucagon-like Peptide-1 and Peptide YY

Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects

Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

Gut Hormones After Roux-en-Y Gastric Bypass (RYGBP) Plus Gastric Fundus Resection

The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus

Non-Interventional Study on Safety of Liraglutide in Subjects With Type 2 Diabetes

Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1

Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes

Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass

Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)

Glucolipotoxicity and Type 2 Diabetes

Plasma Levels of Glucagon-like Peptide-2 and Dyspepsia in Patients With Extraintestinal Cancer During Chemotherapy

Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes

Liraglutide Treatment to Patients With Severe Renal Insufficiency

Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes

Beta Cell Function in (Pre)Type 1 Diabetes

Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes

Peanuts Second Meal Glycemic Response

Pharmacogenetics of Ace Inhibitor-Associated Angioedema

Liraglutide and Heart Failure in Type 2 Diabetes

The Effects of Bethanechol on Glucose Homeostasis

Role of Aprotinin in Glucagon Degradation, Measurement by Radioimmunoactive Method (RIA) I125

The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)

Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus

GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis

Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy

Diet Oil Induced Stimulation of GLP-1

The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes

Gastric and Intestinal Satiation in Obese and Normal Weight Healthy People

The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis

Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure

Glutamine and Insulin Sensitivity in Type I Diabetes

A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

Identifying Potential Effects of Liraglutide on Degenerative Changes

Protein, Amino Acids & Insulin & Glucagon Secretion in Humans

The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus

Physiologic Response to Glucagon at Varying Insulin Levels

Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2

Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes

Predicting Response to Incretin Based Agents in Type 2 Diabetes

Adding Liraglutide to High Dose Insulin: Breaking the Cycle

Safety and Tolerability of Liraglutide in Healthy Male Volunteers

Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes

Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes

Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers

Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function

The Effect of GLP-1 on the Inhibition of Glucagon Secretion

Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function

Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women

Comparison of Two Liraglutide Formulations in Healthy Volunteers

Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes

Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes

Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes

Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes

Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers

Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes

Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group

Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent

An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes

Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone

Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers

Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy

Comparison of Three Liraglutide Formulations in Healthy Volunteers

Bioequivalence of Two Liraglutide Formulations in Healthy Volunteers

Comparison of Two Liraglutide Formulations in Healthy Subjects

Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers

Effect of Liraglutide on Heart Frequency in Healthy Volunteers

Study of RO6807952 in Patients With Diabetes Mellitus Type 2

Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes

Metabolism and Excretion of Liraglutide in Healthy Male Volunteers

Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications

Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH

Comparison of Closed-loop Operation After Morning Meal With and Without Carbohydrate Counting

FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)

Effects of DPP-4 Inhibition on Triglycerides

The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes

Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes

Liraglutide Use in Prader-Willi Syndrome

Liraglutide Effects on Memory in Healthy Subjects

Artificial Pancreas Control System in an Inpatient Setting

Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia

Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea

A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI

Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes

Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure

DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists

The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic Subjects

A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus

GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic Patients

A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes

Resveratrol-Leucine Metabolite Synergy in Pre-diabetes

The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes

Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin

Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding

Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic Patients

The Effect of LY2409021 on Blood Sugar Levels When Glucagon Levels Are Increased in Healthy Male Participants

Modulation of Human Myocardial Metabolism by GLP-1 Dose Response

Exercise, Glucose Kinetics, and the Incretin Effect

Contribution of Pancreatic αcells Function to Blood Glucose Regulation in Chinese Type 2 Diabetics- the Effect of Sitagliptin on Glucagon Secretion, Insulin Secretion and Insulin Resistance in Chinese Type 2 Diabetics

The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)

Liraglutide in Type 1 Diabetes

Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes

The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers

Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers

Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment

A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes

Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin

GLP-1 and Non-exercise Activity Thermogenesis in RHZ

Study of LY2409021 in Participants With Type 1 Diabetes

Treatment With Sitagliptin in Non-obese Japanese Patients With Type 2 Diabetes Mellitus

Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics

The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion

Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM

The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification

Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients

Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Small Bowel Crohn Disease

Effect of Glucagon on Uterine Contractility at the Time of Embryo Transfer in in Vitro Fertilization

Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy Controls

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

The Microvascular Function of GLP-1 and Its Analogues

Testing State of the Art Remote Glucose Monitoring at Diabetes Camp

Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Type 1 Diabetes

Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients

Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes Mellitus

The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy Volunteers

Physical Training and the Incretin Effect

Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes

Liraglutide in Type 1 Diabetes

Liraglutide in the Treatment of Type 1 Diabetes Mellitus

To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes

A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese

GIP and GLP-1 in Type 1 Diabetes

GLP-1 and Microvascular Function in Type 2 Diabetes

Sitagliptin in Type I Diabetic Patients

SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies

Immune Biomarkers of Residual Beta-cell Mass in Type 1 Diabetes

Hyperglycemia and the Extra-pancreatic Effect of Incretins

Liraglutide In Overweight Patients With Type 1 Diabetes

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults and Adolescents With Type 1 Diabetes

Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting

Blood Pressure Outcomes With Liraglutide Therapy

Bone Marrow Derived Stem Cell Transplantation in T2DM

Effect of GLP-1 on Postprandial Lipid Metabolism

Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients

Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas

Glucagon-like Peptide (GLP) Utilization and Safety

A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus

RISE Adult Medication Study

Rapid Versus Slow Ingestion of Mixed Meal: Influence on Islet and Incretin Hormone Secretion in Healthy Volunteers

Incretin Effect on the Immunological Phenotype

Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.

Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users

52 Week Trial of Liraglutide in Type 1 Diabetes

A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years

Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

Incretin Regulation of Insulin Secretion in Monogenic Diabetes

Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones

The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes

Mixed Meal Test in Type 1 Diabetes: Optimization of Artificial Pancreas-Pilot Study

Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)

Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency

Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome

Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus

Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes

A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks

The Summer Camp Study: Blood Glucose Control With a Bi-Hormonal Bionic Endocrine Pancreas

Biobehavioral Mechanisms of Glucose Variability

The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes

Evaluating Liraglutide in Alzheimer's Disease

A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.

Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?

The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease

Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes

GLP-1 and Hypoglycemia

Etiology, Assessment and Treatment of Post-gastric Bypass Severe Hypoglycemia

A Study of LY3025876 in Participants With Diabetes

Artificial Pancreas Control System in an Outpatient Setting

Oral Glucose Stimulation in Normal-weight and Obese Volunteers

Liraglutide in Newly Onset Type 1 Diabetes.

Splanchnic Blood Redistribution After Incretin Hormone Infusion and Obesity Surgery

Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe

Polycystic Ovary Syndrome and Liraglutide

Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans

Closed-loop Control of Overnight Glucose Levels in Adults and Adolescents With Type 1 Diabetes

Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin

Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin

Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages

Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes

Pharmacokinetics Study of Gamma-aminobutyric Acid

Liraglutide Hospital Discharge Trial

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus

Closed-loop Control of Glucose Levels After Meal Intake in Adults With Type 1 Diabetes

Closed-loop Control of Glucose Levels (Artificial Pancreas) During Exercise in Adults With Type 1 Diabetes

Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.

Incretin and KATP Channels

Investigating Brown Adipose Tissue Activation in Humans

Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D

Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery

Effects of Xenin-25 on Insulin Secretion and Gastric Emptying in Humans With and Without a Complete Truncal Vagotomy

The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion

Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus

Metformin's Effect on Glucagon-induced Glucose Production and Protein Metabolism.

Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2

Evaluate the Immunogenicity of a Novel Glucagon Formulation

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 60 Hours in Adults With Type 1 Diabetes

The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study

Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe Hypoglycemia

The Usefulness of Postprandial Triglyceride for Assessment of Cardiovascular Risk

A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers